{"DataElement":{"publicId":"2431543","version":"1","preferredName":"Breast Positive Surgical Margin Neoplasm Present NCI Concept Code","preferredDefinition":"Indicates the degree of invasiveness of neoplasm at the positive breast margin.","longName":"2431338v1.0:2433660v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2431338","version":"1","preferredName":"Breast Positive Surgical Margin Neoplasm","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:definition pending_An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic","longName":"2431276v1.0:2431212v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2431276","version":"1","preferredName":"Breast Positive Surgical Margin","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:definition pending","longName":"C12971:C48620","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Surgical Margin","conceptCode":"C48620","definition":"Indicates the presence of tumor cells at the edge of a surgically excised specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF14D-AD7F-3A55-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2431212","version":"1","preferredName":"Neoplasm","preferredDefinition":"An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic","longName":"C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCE203-C860-3264-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCFE3F-7D67-3F85-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"03/31/14 jc released UMLLOADER_CAP content per R. Crowley.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2433660","version":"1","preferredName":"Breast Positive Surgical Margin Neoplasm Present NCI Concept Code","preferredDefinition":"Indicates what neoplasm is present at margin._A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","longName":"2433660v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Invasive Breast Carcinoma","valueDescription":"Invasive Breast Carcinoma","ValueMeaning":{"publicId":"2581143","version":"1","preferredName":"Invasive Breast Carcinoma","longName":"2581143","preferredDefinition":"A carcinoma that infiltrates the breast parenchyma. The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU). Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ. It is the most common carcinoma affecting women. --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma","conceptCode":"C9245","definition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A04-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06BB6599-4221-21F1-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-29","modifiedBy":"ONEDATA","dateModified":"2005-11-29","deletedIndicator":"No"},{"value":"Ductal Carcinoma in-situ","valueDescription":"Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"2581232","version":"1","preferredName":"Ductal Breast Carcinoma In Situ","longName":"2581232","preferredDefinition":"Ductal carcinoma in situ (DCIS) is a carcinoma entirely confined to the mammary ducts. There is no evidence of invasion of the basement membrane. Currently, DCIS is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A5D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06BB6599-4223-21F1-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-29","modifiedBy":"ONEDATA","dateModified":"2005-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2183782","version":"1","preferredName":"NCIP","preferredDefinition":"Cancer Biomedical Informatics Grid","longName":"NCIP","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DACB2549-3BE3-73F7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433292","version":"1","preferredName":"NCI Concept Code","preferredDefinition":"A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","longName":"C43516","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NCI Concept Code","conceptCode":"C43516","definition":"A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"062A6784-EC8C-6CFB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-22","modifiedBy":"ONEDATA","dateModified":"2005-11-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06459C26-BF84-6BA7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CHILLIJ","dateModified":"2014-03-31","changeDescription":"03/31/14 jc released UMLLOADER_CAP content per R. Crowley; added CAP CSI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2857187","version":"1","longName":"CAP Cancer Checklists","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812063","version":"1","longName":"edu.upmc.opi.cabig.caties.cap.domain.breast","context":"NCIP"}]}],"AlternateNames":[{"name":"edu.upmc.opi.cabig.caties.cap.domain.breast.BreastPositiveSurgicalMargin.neoplasmPresent","type":"UML Qualified Attr","context":"NCIP"},{"name":"BreastPositiveSurgicalMargin:neoplasmPresent","type":"UML Class:UML Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Present at margin","type":"Preferred Question Text","description":"Present at margin","url":null,"context":"NCIP"}],"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE4E74-B3B1-583A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"CHILLIJ","dateModified":"2014-03-31","changeDescription":"03/31/14 jc released UMLLOADER_CAP content per R. Crowley.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}